Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway.
暂无分享,去创建一个
F. Piscitelli | V. Di Marzo | A. Calignano | C. Cristiano | S. Maione | V. de Novellis | L. Cristino | F. Guida | L. Luongo | E. Palazzo | S. Boccella | R. Imperatore | M. Iannotta | C. Belardo | R. Romano | Lea Tunisi | A. Farina | Mariacristina Mazzitelli
[1] S. Cuzzocrea,et al. Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome , 2018, PloS one.
[2] Conor D. Cox,et al. Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus , 2018, Cerebral cortex.
[3] V. Neugebauer,et al. Amygdala Plasticity and Pain , 2017, Pain research & management.
[4] Marina Flaibani,et al. mTOR-Dependent Cell Proliferation in the Brain , 2017, BioMed research international.
[5] M. Grilli. Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies , 2017, Journal of pain research.
[6] Yu Kyeong Kim,et al. Upregulation of prefrontal metabotropic glutamate receptor 5 mediates neuropathic pain and negative mood symptoms after spinal nerve injury in rats , 2017, Scientific Reports.
[7] Anna L. Blobaum,et al. mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome , 2017, Science Translational Medicine.
[8] D. Centonze,et al. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum , 2017, Scientific Reports.
[9] H. Lester,et al. TRPV1 regulates excitatory innervation of OLM neurons in the hippocampus , 2017, Nature Communications.
[10] F. Piscitelli,et al. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor , 2017, Scientific Reports.
[11] M. Cha,et al. Inhibition of Mammalian Target of Rapamycin (mTOR) Signaling in the Insular Cortex Alleviates Neuropathic Pain after Peripheral Nerve Injury , 2017, Front. Mol. Neurosci..
[12] F. Rossi,et al. Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury , 2017, Front. Pharmacol..
[13] V. Marzo,et al. Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation. , 2016, Pharmacological research.
[14] Gary Lynch,et al. A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation , 2016, eNeuro.
[15] M. Zhuo,et al. Metabotropic Glutamate Receptor Dependent Cortical Plasticity in Chronic Pain , 2016, Current neuropharmacology.
[16] S. Rajagopal,et al. The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors* , 2016, The Journal of Biological Chemistry.
[17] T. Banke. Inhibition of TRPV1 channels enables long-term potentiation in the entorhinal cortex , 2016, Pflügers Archiv - European Journal of Physiology.
[18] A. Usiello,et al. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice , 2015, Molecular Brain.
[19] S. Cuzzocrea,et al. Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity , 2015, PloS one.
[20] Giorgio A Ascoli,et al. Quantitative Investigations of Axonal and Dendritic Arbors , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[21] R. Citraro,et al. Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice , 2015, Molecular metabolism.
[22] R. Kuner. Spinal excitatory mechanisms of pathological pain. , 2015, Pain.
[23] D. De Gregorio,et al. MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice , 2015, Pain.
[24] Jufang He,et al. Time course of the dependence of associative memory retrieval on the entorhinal cortex , 2014, Neurobiology of Learning and Memory.
[25] R. Huganir,et al. Postsynaptic insertion of AMPA receptor onto cortical pyramidal neurons in the anterior cingulate cortex after peripheral nerve injury , 2014, Molecular Brain.
[26] Fengyu Liu,et al. Exacerbation of tonic but not phasic pain by entorhinal cortex lesions , 2014, Neuroscience Letters.
[27] Paul D. Morton,et al. Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling , 2014, Brain, Behavior, and Immunity.
[28] D. De Gregorio,et al. Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions. , 2014, Journal of neurophysiology.
[29] Neil Burgess,et al. What do grid cells contribute to place cell firing? , 2014, Trends in Neurosciences.
[30] Livio Luongo,et al. Endocannabinoids and neuropathic pain: focus on neuron–glia and endocannabinoid–neurotrophin interactions , 2014, The European journal of neuroscience.
[31] R. Dantzer,et al. Neuroinflammation and Comorbidity of Pain and Depression , 2014, Pharmacological Reviews.
[32] C. Breivogel,et al. The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain , 2013, Journal of receptor and signal transduction research.
[33] Giorgio Cruccu,et al. Reappraising neuropathic pain in humans—how symptoms help disclose mechanisms , 2013, Nature Reviews Neurology.
[34] Seralynne D Vann,et al. Dismantling the Papez circuit for memory in rats , 2013, eLife.
[35] G. Busetto,et al. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons , 2013, Proceedings of the National Academy of Sciences.
[36] S. Maione,et al. Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat , 2013, Molecular pain.
[37] Jun Chen,et al. The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways , 2013, Molecular Pain.
[38] D. Siniscalco,et al. TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. , 2012, Cerebral cortex.
[39] Luke A Henderson,et al. Pain and Plasticity: Is Chronic Pain Always Associated with Somatosensory Cortex Activity and Reorganization? , 2012, The Journal of Neuroscience.
[40] R. Meli,et al. Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease , 2012, Neuropsychopharmacology.
[41] Jelena Radulovic,et al. Abnormalities in Hippocampal Functioning with Persistent Pain , 2012, The Journal of Neuroscience.
[42] D. Piomelli,et al. 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. , 2012, Cell metabolism.
[43] S. Maione,et al. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. , 2012, CNS & neurological disorders drug targets.
[44] L. Kerbauy,et al. Effect of isolation rearing on the expression of AMPA glutamate receptors in the hippocampal formation , 2011, Journal of psychopharmacology.
[45] M. Barrot,et al. A Time-Dependent History of Mood Disorders in a Murine Model of Neuropathic Pain , 2011, Biological Psychiatry.
[46] T. Bisogno,et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice , 2011, Nutrition & metabolism.
[47] Jun Wang,et al. Peripheral Nerve Injury Leads to Working Memory Deficits and Dysfunction of the Hippocampus by Upregulation of TNF-α in Rodents , 2011, Neuropsychopharmacology.
[48] J. Wojtowicz,et al. Analyzing Dendritic Growth in a Population of Immature Neurons in the Adult Dentate Gyrus Using Laminar Quantification of Disjointed Dendrites , 2011, Front. Neurosci..
[49] D. Finn,et al. The effect of pain on cognitive function: A review of clinical and preclinical research , 2011, Progress in Neurobiology.
[50] O. von Bohlen und Halbach,et al. Capsaicin-Induced Changes in LTP in the Lateral Amygdala Are Mediated by TRPV1 , 2011, PloS one.
[51] F. Rossi,et al. The Role of Cannabinoid Receptors in the Descending Modulation of Pain , 2010, Pharmaceuticals.
[52] S. Petrosino,et al. N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. , 2010, Biochimie.
[53] J. Wierońska,et al. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs , 2009, Neurochemistry International.
[54] A. Hohmann,et al. The endocannabinoid system and pain. , 2009, CNS & neurological disorders drug targets.
[55] K. Svoboda,et al. Experience-dependent structural synaptic plasticity in the mammalian brain , 2009, Nature Reviews Neuroscience.
[56] G. Godlewski,et al. Receptors for acylethanolamides-GPR55 and GPR119. , 2009, Prostaglandins & other lipid mediators.
[57] I. Izquierdo,et al. BDNF is essential to promote persistence of long-term memory storage , 2008, Proceedings of the National Academy of Sciences.
[58] B. Cravatt,et al. A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.
[59] A. Bilbao,et al. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain , 2007, PAIN®.
[60] M. Tanabe,et al. Altered hippocampal long-term potentiation after peripheral nerve injury in mice. , 2007, European journal of pharmacology.
[61] S. Hjorth,et al. The orphan receptor GPR55 is a novel cannabinoid receptor , 2007, British journal of pharmacology.
[62] F. Holsboer,et al. Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice , 2007, The Journal of Neuroscience.
[63] A. Hohmann,et al. Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α , 2006, Journal of Pharmacology and Experimental Therapeutics.
[64] E. Kandel,et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus , 2006, Proceedings of the National Academy of Sciences.
[65] Robert J. Lefkowitz,et al. G-protein-coupled Receptor Kinase Specificity for β-Arrestin Recruitment to the β2-Adrenergic Receptor Revealed by Fluorescence Resonance Energy Transfer* , 2006, Journal of Biological Chemistry.
[66] T. Freund,et al. Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.
[67] Michael Häusser,et al. Dendritic Calcium Spikes Are Tunable Triggers of Cannabinoid Release and Short-Term Synaptic Plasticity in Cerebellar Purkinje Neurons , 2006, The Journal of Neuroscience.
[68] C. Guaza,et al. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures , 2005, Glia.
[69] Masanobu Kano,et al. Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum , 2005, The Journal of Neuroscience.
[70] David Attwell,et al. Endocannabinoid signaling depends on the spatial pattern of synapse activation , 2005, Nature Neuroscience.
[71] D. Piomelli,et al. The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide , 2005, Molecular Pharmacology.
[72] Su-Jane Wang. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. , 2003, European journal of pharmacology.
[73] R. Melzack,et al. Blocking NMDA Receptors in the Hippocampal Dentate Gyrus with AP5 Produces Analgesia in the Formalin Pain Test , 2001, Experimental Neurology.
[74] L. Berrino,et al. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception , 2001, Neuropharmacology.
[75] C. Woolf,et al. Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.
[76] F. J. van der Staay,et al. Behavioral effects of apamin, a selective inhibitor of the SKCa-channel, in mice and rats , 1999, Neuroscience & Biobehavioral Reviews.
[77] S. Ikonen,et al. Effects of apamin on memory processing of hippocampal-lesioned mice. , 1999, European journal of pharmacology.
[78] D. Jane,et al. Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.
[79] S. Yamamoto,et al. Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand , 1998, FEBS letters.
[80] H J Gundersen,et al. The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.
[81] A. Gol,et al. Hippocampectomy for relief of intractable pain. , 1966, Texas medicine.
[82] S. Petrosino,et al. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. , 2016, Veterinary journal.
[83] D. Finn,et al. Impaired recognition memory and cognitive flexibility in the rat L5–L6 spinal nerve ligation model of neuropathic pain , 2016, Scandinavian journal of pain.
[84] E. Kandel,et al. Structural changes accompanying memory storage. , 1993, Annual review of physiology.